{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:30:04Z","timestamp":1770823804478,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6794,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1023\/a:1011195708834","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T11:26:45Z","timestamp":1040642805000},"page":"853-858","source":"Crossref","is-referenced-by-count":25,"title":["Among diffuse large B-cell lymphomas, T-cell-rich\/histiocyte-rich BCL and CD30 + anaplastic B-cell subtypes exhibit distinct clinical features"],"prefix":"10.1016","volume":"12","author":[{"given":"B.","family":"Maes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Anastasopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Teodorovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Achten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"De Wolf-Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1023\/A:1011195708834_bb0010","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A Revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group (see comments)","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"10","key":"10.1023\/A:1011195708834_bb0015","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood.V87.10.4358.bloodjournal87104358","volume":"87","author":"Pittaluga","year":"1996","journal-title":"Blood"},{"issue":"II","key":"10.1023\/A:1011195708834_bb0020","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin\u2019s Lymphoma","volume":"89","author":"The Non-Hodgkin\u2019s Lymphoma Classification Project","year":"1997","journal-title":"Blood"},{"issue":"11","key":"10.1023\/A:1011195708834_bb0025","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1182\/blood.V88.11.4085.bloodjournal88114085","article-title":"Lymphoma classification \u2013 the gap between biology and clinical management is closing","volume":"88","author":"Hiddemann","year":"1996","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1023\/A:1011195708834_bb0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10428199909083390","article-title":"Clinicopathological evaluation of the Revised European-American Classification of Lymphoid Neoplasms (R.E.A.L.) in Japan","volume":"34","author":"Isobe","year":"1999","journal-title":"Leuk Lymph"},{"issue":"12","key":"10.1023\/A:1011195708834_bb0035","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting. Airlie House. Virginia, November. 1997","volume":"10","author":"Harris","year":"1999","journal-title":"Ann Oncol"},{"issue":"8580","key":"10.1023\/A:1011195708834_bb0040","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel Classification for lymphomas","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"issue":"7","key":"10.1023\/A:1011195708834_bb0045","first-page":"2291","article-title":"Subclassification of diffuse large B-cell lymphomas according to the Kiel Classification. Distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor","volume":"89","author":"Engelhard","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1023\/A:1011195708834_bb0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00000478-199201000-00006","article-title":"Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin\u2019s disease, paragranuloma subtype","volume":"16","author":"Delabie","year":"1992","journal-title":"Am J Surg Pathol"},{"issue":"4, Suppl","key":"10.1023\/A:1011195708834_bb0055","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C","article-title":"Immunologic characterization of human malignant lymphomas","volume":"34","author":"Lukes","year":"1974","journal-title":"Cancer"},{"issue":"10","key":"10.1023\/A:1011195708834_bb0060","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"Summary and description of a working formulation for clinical usage. The Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project","volume":"49","author":"National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas","year":"1982","journal-title":"Cancer"},{"issue":"25","key":"10.1023\/A:1011195708834_bb0065","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM197812212992503","article-title":"Clinical relevance of the histopathological subclassification of diffuse \u2018histiocytic\u2019 lymphoma","volume":"299","author":"Strauchen","year":"1978","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1023\/A:1011195708834_bb0070","first-page":"241","article-title":"The Lukes and Collins classification of non-Hodgkin\u2019s lymphomas. 1. A histological reappraisal of 301 cases","volume":"90","author":"Alavaikko","year":"1982","journal-title":"Acta Pathol Microbiol Immunol Scand A"},{"issue":"4","key":"10.1023\/A:1011195708834_bb0075","first-page":"251","article-title":"The Lukes and Collins classification of non-Hodgkin\u2019s lymphomas. 2. A survival study of 301 patients","volume":"90","author":"Aine","year":"1982","journal-title":"Acta Pathol Microbiol Immunol Scand A"},{"issue":"11","key":"10.1023\/A:1011195708834_bb0080","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/1097-0142(19871201)60:11<2704::AID-CNCR2820601121>3.0.CO;2-#","article-title":"Malignant lymphomas of follicular center cell origin in man. VI. Large cleaved cell lymphoma","volume":"60","author":"Stein","year":"1987","journal-title":"Cancer"},{"issue":"8","key":"10.1023\/A:1011195708834_bb0085","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1200\/JCO.1990.8.8.1370","article-title":"Large-cell lymphomas: Clinical and prognostic features","volume":"8","author":"Stein","year":"1990","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1023\/A:1011195708834_bb0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood.V58.1.45.45","article-title":"Factors predicting longterm survival in diffuse mixed, histiocytic, or undifferentiated lymphoma","volume":"58","author":"Fisher","year":"1981","journal-title":"Blood"},{"issue":"3","key":"10.1023\/A:1011195708834_bb0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/1097-0142(19820801)50:3<439::AID-CNCR2820500310>3.0.CO;2-P","article-title":"The usefulness of the Lukes-Collins classification in identifying subsets of diffuse histiocytic lymphoma responsive to chemotherapy","volume":"50","author":"Newcomer","year":"1982","journal-title":"Cancer"},{"issue":"5","key":"10.1023\/A:1011195708834_bb0100","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1182\/blood.V60.5.1068.1068","article-title":"The clinical significance of the morphological subdivision of diffuse \u2018histiocytic\u2019 lymphoma: A study of 162 patients treated by the Southwest Oncology Group","volume":"60","author":"Nathwani","year":"1982","journal-title":"Blood"},{"issue":"4","key":"10.1023\/A:1011195708834_bb0105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/1097-0142(19820815)50:4<690::AID-CNCR2820500412>3.0.CO;2-L","article-title":"Morphologic types of diffuse large-cell lymphoma","volume":"50","author":"Warnke","year":"1982","journal-title":"Cancer"},{"issue":"10","key":"10.1023\/A:1011195708834_bb0110","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/1097-0142(19850515)55:10<2442::AID-CNCR2820551024>3.0.CO;2-9","article-title":"Comparison of the working formulation of non-Hodgkin\u2019s lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution","volume":"55","author":"Ersboll","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"10.1023\/A:1011195708834_bb0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(86)90285-8","article-title":"Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 years","volume":"81","author":"Lieberman","year":"1986","journal-title":"Am J Med"},{"issue":"9","key":"10.1023\/A:1011195708834_bb0120","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/1097-0142(19911101)68:9<1988::AID-CNCR2820680924>3.0.CO;2-A","article-title":"Clinical significance of morphologic subdivision in diffuse large-cell lymphoma","volume":"68","author":"Kwak","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1023\/A:1011195708834_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/jcp.47.1.33","article-title":"Relation of CD30 expression to survival and morphology in large cell B cell lymphomas","volume":"47","author":"Noorduyn","year":"1994","journal-title":"J Clin Pathol"},{"issue":"8","key":"10.1023\/A:1011195708834_bb0130","first-page":"2697","article-title":"ALK+ lymphoma: Clinicopathological findings and outcome","volume":"93","author":"Falini","year":"1999","journal-title":"Blood"},{"issue":"11","key":"10.1023\/A:1011195708834_bb0135","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","article-title":"Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma","volume":"93","author":"Gascoyne","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1023\/A:1011195708834_bb0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jnci\/93.1.22","article-title":"Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin\u2019s lymphoma: Randomized phase III EORTC study","volume":"93","author":"Kluin-Nelemans","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1023\/A:1011195708834_bb0145","first-page":"3509","article-title":"Lymphomas expressing ALK fusion protein(s) other than NPM-ALK","volume":"94","author":"Falini","year":"1999","journal-title":"Blood"},{"issue":"2","key":"10.1023\/A:1011195708834_bb0150","first-page":"343","article-title":"The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23\/ALK rearrangements","volume":"151","author":"Pittaluga","year":"1997","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1023\/A:1011195708834_bb0155","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: A single disease with a broad spectrum of morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1023\/A:1011195708834_bb0160","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood.V89.4.1394","article-title":"Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1","volume":"89","author":"Pulford","year":"1997","journal-title":"Blood"},{"issue":"6769","key":"10.1023\/A:1011195708834_bb0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419479878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419479878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/6\/853\/19479394\/12-6-853.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T06:59:30Z","timestamp":1582181970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419479878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0923753419479878"],"URL":"https:\/\/doi.org\/10.1023\/a:1011195708834","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}